Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

生物技术研究

Los Angeles,California 5,328 位关注者

PURPOSEFUL. PRECISE. POWERFUL.

关于我们

Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Armata is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific cGMP manufacturing. More information is available at www.armatapharma.com

网站
https://www.armatapharma.com
所属行业
生物技术研究
规模
51-200 人
总部
Los Angeles,California
类型
上市公司
创立
2019
领域
Biotechnology、Therapeutics、Drug Development、Infectious Disease、Microbiome、Targeted Antimicrobials、Bacteriophage、Synthetic Biology、Engineered Phage、targeted phage-based drugs、antimicrobial peptides、Phage、Synthetic Biology和Clinical-Stage

地点

Armata Pharmaceuticals, Inc.员工

动态

相似主页

查看职位

融资